At Excelra, we empower life sciences and healthcare innovators to accelerate the promise of Precision Medicine—where therapies are tailored not just to populations, but to individual patients. Our data-driven approach blends AI/ML, biomarker discovery, genomics, and real-world data to unlock actionable insights across the drug development and clinical value chain.
Precision Medicine, Powered by Data.
Delivered by Excelra
Why precision medicine needs precision data
Precision medicine success hinges on deep integration of multi-omics data, real-world evidence, digital biomarkers, and clinical outcomes. But siloed systems and unstructured datasets often obscure insights.
Excelra bridges this gap—offering curated, harmonized, and context-enriched data that powers confident decisions in:
- Biomarker discovery and validation
- Target identification and prioritization
- Companion diagnostics
- Patient stratification and trial enrichment
- Digital biomarker development
- Post-market surveillance and real-world insights
Our capabilities in precision medicine informatics
AI/ML for biomarker discovery
Uncover novel biomarkers using predictive models trained on curated multi-omics and literature datasets.
Genomic & transcriptomic analytics
Annotate and interpret NGS data to support indication expansion, target validation, and personalized therapies.
Clinical data harmonization
Clean and align disparate datasets across trials, EHRs, and registries for unified insights.
Digital biomarkers
Partner in extracting and validating sensor-derived endpoints using wearable data and ML models.
Knowledge graphs & insight engines
Interlink molecular, clinical, and phenotypic data for hypothesis generation and cohort design.
Multi-omics data integration
Integrate and analyze genomics, proteomics, metabolomics, and epigenomics data to enable tailored treatment strategies.
How Excelra powers precision medicine
AI & ML for biomarker discovery
As highlighted in “roadmap to biomarker discovery,” our curated datasets fuel predictive models that
- Identify novel biomarkers for disease stratification
- Predict patient responses for trial enrichment
- Enable development of companion diagnostics (CDx)
Multi-omics integration
From “FGFR3 mutations in bladder cancer,” we know the power of linking genotypic and phenotypic data
- Combine genomics, transcriptomics, proteomics
- Decode complex pathways in oncology and rare diseases
- Support NGS-based drug development with precision annotation
Insight engines & knowledge graphs
Precision medicine needs intelligent search and discovery. As noted in “leveraging AI and data analytics”
We:
- Interlink clinical, molecular, and phenotypic datasets
- Enable researchers to uncover hidden relationships
- Deliver AI-powered dashboards for target-disease-drug mapping
Explore how our informatics and data science expertise helps biopharma, diagnostics, and digital health companies translate complexity into clarity.
Ready to get more from data?
Tell us about your objectives. We’ll help get you there.
"*" indicates required fields
